Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy.
Blasco M, Martínez-Roca A, Rodríguez-Lobato LG, Garcia-Herrera A, Rosiñol L, Castro P, Fernández S, Quintana LF, Cibeira MT, Bladé J, Fernández de Larrea C, Tovar N, Jimenez R, Poch E, Guillen E, Campistol JM, Carreras E, Diaz-Ricart M, Palomo M. Blasco M, et al. Among authors: carreras e. Br J Haematol. 2021 Apr;193(1):181-187. doi: 10.1111/bjh.16796. Epub 2020 May 29. Br J Haematol. 2021. PMID: 32469083 Free article.
High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission.
Nadal E, Giné E, Bladé J, Esteve J, Rosiñol L, Fernández-Avilés F, Marin P, Martinez C, Rovira M, Urbano-Ispizua A, Carreras E, Montserrat E. Nadal E, et al. Among authors: carreras e. Bone Marrow Transplant. 2004 Jan;33(1):61-4. doi: 10.1038/sj.bmt.1704313. Bone Marrow Transplant. 2004. PMID: 14704657 Clinical Trial.
Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Carreras E, Rosiñol L, Terol MJ, Alegre A, de Arriba F, García-Laraña J, Bello JL, García R, León A, Martínez R, Peñarrubia MJ, Poderós C, Ribas P, Ribera JM, San Miguel J, Bladé J, Lahuerta JJ; Spanish Myeloma Group/PETHEMA. Carreras E, et al. Biol Blood Marrow Transplant. 2007 Dec;13(12):1448-54. doi: 10.1016/j.bbmt.2007.08.002. Biol Blood Marrow Transplant. 2007. PMID: 18022574 Free article. Clinical Trial.
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M, Diaz-Ricart M, Carbo C, Rovira M, Fernandez-Aviles F, Escolar G, Eissner G, Holler E, Carreras E. Palomo M, et al. Among authors: carreras e. Biol Blood Marrow Transplant. 2009 May;15(5):537-46. doi: 10.1016/j.bbmt.2009.01.013. Biol Blood Marrow Transplant. 2009. PMID: 19361745 Free article.
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.
Fernández de Larrea C, Martínez C, Gaya A, López-Guillermo A, Rovira M, Fernández-Avilés F, Lozano M, Bosch F, Esteve J, Nomdedeu B, Montserrat E, Carreras E. Fernández de Larrea C, et al. Among authors: carreras e. Ann Oncol. 2010 Jun;21(6):1211-1216. doi: 10.1093/annonc/mdp487. Epub 2009 Nov 4. Ann Oncol. 2010. PMID: 19889622 Free article.
547 results